Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Journal of Clinical Pharmacology
|
May 19, 2006
Pharmacokinetics, tolerability, and performance of a novel matrix transdermal delivery system of fentanyl relative to the commercially available reservoir formulation in healthy subjects
Jean-Francois Marier, Mary Lor, Diane Potvin, et al.
Therapeutic Drug Monitoring
|
September 24, 2004
Effects of ciprofloxacin on the stereoselective disposition of mexiletine in man
Line Labbé, N Michelle Robitaille, Christophe Lefez, et al.
AIDS (London, England)
|
April 26, 2011
Effects of tesamorelin on inflammatory markers in HIV patients with excess abdominal fat: relationship with visceral adipose reduction
Takara L Stanley, Julian Falutz, Jean-Claude Mamputu, et al.
Plos One
|
March 25, 2021
Characteristics and relationship between hyperphagia, anxiety, behavioral challenges and caregiver burden in Prader-Willi syndrome
Nathalie Kayadjanian, Caroline Vrana-Diaz, Jessica Bohonowych, et al.
Journal of Clinical and Translational Science
|
February 27, 2023
Effect of tesamorelin in people with HIV with and without dorsocervical fat: Post hoc analysis of phase III double-blind placebo-controlled trial
Farah Rahman, Taryn McLaughlin, Pedro Mesquita, et al.
Pharmaceutical Statistics
|
February 11, 2011
Additional results for 'Sequential design approaches for bioequivalence studies with crossover designs'
Timothy H Montague, Diane Potvin, Charles E Diliberti, et al.
Pharmaceutical Statistics
|
August 22, 2007
Sequential design approaches for bioequivalence studies with crossover designs
Diane Potvin, Charles E DiLiberti, Walter W Hauck, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 18, 2010
Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data
Julian Falutz, Jean-Claude Mamputu, Diane Potvin, et al.
Cancer Chemotherapy and Pharmacology
|
December 15, 2017
Phase I/II study of mocetinostat in combination with gemcitabine for patients with advanced pancreatic cancer and other advanced solid tumors
Emily Chan, E Gabriela Chiorean, Peter J O'Dwyer, et al.
Pharmaceutical Statistics
|
November 6, 2015
Optimal adaptive sequential designs for crossover bioequivalence studies
Jialin Xu, Charles Audet, Charles E DiLiberti, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Journal of Clinical Pharmacology
|
May 19, 2006
Pharmacokinetics, tolerability, and performance of a novel matrix transdermal delivery system of fentanyl relative to the commercially available reservoir formulation in healthy subjects
Jean-Francois Marier, Mary Lor, Diane Potvin, et al.
Therapeutic Drug Monitoring
|
September 24, 2004
Effects of ciprofloxacin on the stereoselective disposition of mexiletine in man
Line Labbé, N Michelle Robitaille, Christophe Lefez, et al.
AIDS (London, England)
|
April 26, 2011
Effects of tesamorelin on inflammatory markers in HIV patients with excess abdominal fat: relationship with visceral adipose reduction
Takara L Stanley, Julian Falutz, Jean-Claude Mamputu, et al.
Plos One
|
March 25, 2021
Characteristics and relationship between hyperphagia, anxiety, behavioral challenges and caregiver burden in Prader-Willi syndrome
Nathalie Kayadjanian, Caroline Vrana-Diaz, Jessica Bohonowych, et al.
Journal of Clinical and Translational Science
|
February 27, 2023
Effect of tesamorelin in people with HIV with and without dorsocervical fat: Post hoc analysis of phase III double-blind placebo-controlled trial
Farah Rahman, Taryn McLaughlin, Pedro Mesquita, et al.
Pharmaceutical Statistics
|
February 11, 2011
Additional results for 'Sequential design approaches for bioequivalence studies with crossover designs'
Timothy H Montague, Diane Potvin, Charles E Diliberti, et al.
Pharmaceutical Statistics
|
August 22, 2007
Sequential design approaches for bioequivalence studies with crossover designs
Diane Potvin, Charles E DiLiberti, Walter W Hauck, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 18, 2010
Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data
Julian Falutz, Jean-Claude Mamputu, Diane Potvin, et al.
Cancer Chemotherapy and Pharmacology
|
December 15, 2017
Phase I/II study of mocetinostat in combination with gemcitabine for patients with advanced pancreatic cancer and other advanced solid tumors
Emily Chan, E Gabriela Chiorean, Peter J O'Dwyer, et al.
Pharmaceutical Statistics
|
November 6, 2015
Optimal adaptive sequential designs for crossover bioequivalence studies
Jialin Xu, Charles Audet, Charles E DiLiberti, et al.
Page
of 3